Skip to main content

Table 1 Patient Characteristics

From: A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy

Characteristic

Study Patients (N = 20)

Median age – yrs (range)

65 (38–84)

Sex (no.)

 

   Male

10

   Female

10

WHO Performance Score

 

   0

14

   1

5

   2

1

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us